PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 122 filers reported holding PMV PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,221,761 | -3.6% | 4,596,378 | -1.7% | 0.00% | 0.0% |
| Q2 2023 | $29,278,195 | +52.3% | 4,677,028 | +16.1% | 0.00% | 0.0% |
| Q1 2023 | $19,223,905 | -36.0% | 4,030,169 | +16.8% | 0.00% | 0.0% |
| Q4 2022 | $30,026,894 | -24.9% | 3,451,367 | +2.7% | 0.00% | 0.0% |
| Q3 2022 | $39,987,000 | -16.4% | 3,360,323 | +0.1% | 0.00% | -50.0% |
| Q2 2022 | $47,854,000 | -12.9% | 3,358,144 | +27.2% | 0.00% | +100.0% |
| Q1 2022 | $54,970,000 | -6.3% | 2,640,350 | +4.0% | 0.00% | 0.0% |
| Q4 2021 | $58,670,000 | -10.0% | 2,539,824 | +16.1% | 0.00% | -50.0% |
| Q3 2021 | $65,199,000 | -0.5% | 2,187,923 | +14.1% | 0.00% | 0.0% |
| Q2 2021 | $65,525,000 | +39.7% | 1,918,134 | +34.5% | 0.00% | +100.0% |
| Q1 2021 | $46,897,000 | -43.3% | 1,425,873 | +6.0% | 0.00% | -66.7% |
| Q4 2020 | $82,731,000 | +330.0% | 1,345,015 | +148.1% | 0.00% | +200.0% |
| Q3 2020 | $19,242,000 | – | 542,038 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $9,915,554 | 48.05% |
| OUP Management Co., LLC | 989,232 | $6,073,884 | 13.66% |
| Euclidean Capital LLC | 5,255,286 | $32,267,456 | 3.52% |
| Tri Locum Partners LP | 821,384 | $5,043,298 | 1.61% |
| Ghost Tree Capital, LLC | 705,881 | $4,334,109 | 1.42% |
| Boxer Capital, LLC | 3,163,795 | $19,425,701 | 1.03% |
| Mesirow Financial Investment Management, Inc. | 34,748 | $213,353 | 0.93% |
| Orbimed Advisors | 6,563,077 | $40,297,293 | 0.86% |
| Octagon Capital Advisors LP | 904,000 | $5,550,560 | 0.85% |
| Nextech Invest Ltd. | 421,284 | $2,586,684 | 0.78% |